Targeted therapy
October 14, 2019
The combination of ibrutinib plus rituximab was superior to standard treatment for CLL patients age 70 and younger.
February 9, 2020
Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
February 12, 2020
The TAILORx trial answers questions about when to use chemotherapy to treat the most common type of breast cancer.